You are here

United States

Opinion: The NIH has little to show for the $1 billion spent to study long Covid

...

The National Institutes of Health hasn’t signed up a single patient to test any potential treatments — despite a clear mandate from Congress to study them. And the few trials it is planning have already drawn a firestorm of criticism, especially one intervention that experts and advocates say may actually make some patients’ long Covid symptoms worse.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Two drug combination shows protection against severe COVID-19

Two new randomized, controlled trials published yesterday in the Annals of Internal Medicine describe how drug combinations lowered the risk of severe COVID-19, with one detailing use of the antidepressant fluvoxamine plus the corticosteroid budesonide, and the other outlining the monoclonal antibody duo amubarvimab plus romlusevimab.

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Early steroid use for severe COVID-19 associated with fewer deaths in serious cases

JAMA Network Open has published a new US national cohort study demonstrating that early administration of the steroid dexamethasone was associated with significantly reduced odds of mortality or discharge to hospice in those requiring supplemental oxygen or mechanical ventilation and/or extracorporeal membrane oxygenation.

The effect was not seen, however, in patients who did not require supplemental oxygen or noninvasive positive-pressure ventilation.

...

Country / Region Tags: 
Problem, Solution, SitRep, or ?: 

Pages

Subscribe to United States
howdy folks